Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Companies
Recent news which mentions Companies
< Previous
1
2
...
20
21
22
23
24
25
26
27
28
...
30
31
Next >
Oil giant Saudi Aramco posts 19% drop in first-quarter profit
May 09, 2023
Tickers
OIL
Tags
Energy
Government and politics
Oil and Gas
From
CNBC.com News
Tech's been hit by layoffs. But Singapore is still investing big in its talent — in tech and beyond
May 08, 2023
Tickers
JOBS
Tags
Jobs
Oversea/Chinese Banking Corporation Ltd
Asia News
From
CNBC.com News
Kenvue CEO looks to brand, product innovation to drive growth after IPO
May 05, 2023
Tickers
IPO
IPOS
Tags
Companies
US: News
Biotech and Pharmaceuticals
From
CNBC.com News
J&J's consumer health spinoff Kenvue opens at $25.53, a 16% jump, in public market debut
May 04, 2023
Tickers
IPO
IPOS
Tags
Companies
US: News
Biotech and Pharmaceuticals
From
CNBC.com News
Moderna posts surprise quarterly profit despite waning demand for Covid vaccines
May 04, 2023
Tags
Biotechnology
Pfizer Inc
Johnson & Johnson
From
CNBC.com News
FDA approves GSK's RSV vaccine for older adults, world's first shot against virus
May 03, 2023
Tags
Business News
Biotechnology
Immunizations
From
CNBC.com News
J&J's consumer health business Kenvue is going public this week. Here's what to know
May 03, 2023
Tickers
IPO
IPOS
Tags
Johnson & Johnson
Health care industry
Breaking news
From
CNBC.com News
Pfizer earnings and revenue top expectations despite sales declines
May 02, 2023
Tags
Biotechnology
Pfizer Inc
Health care industry
From
CNBC.com News
Carl Icahn calls Illumina Q1 results ‘very disappointing,’ slams cost-cutting plan
April 28, 2023
Tickers
LAW
LAWS
Tags
US: News
Law and Regulation
Companies
From
CNBC.com News
Merck revenue falls after dramatic drop in sales of Covid antiviral treatment
April 27, 2023
Tags
Biotechnology
Pfizer Inc
Johnson & Johnson
From
CNBC.com News
Illumina CEO touts Grail’s 100% revenue growth amid proxy fight with Icahn
April 26, 2023
Tags
Breaking news
Health care industry
Mergers and acquisitions
From
CNBC.com News
Biogen isn't concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says
April 25, 2023
Tags
Biotech and Pharmaceuticals
Companies
US: News
From
CNBC.com News
FDA grants accelerated approval for Biogen ALS drug that treats rare form of the disease
April 25, 2023
Tags
Ionis Pharmaceuticals Inc
Breaking News: Business
Health & Science
From
CNBC.com News
Johnson & Johnson to price shares of consumer spinoff Kenvue at $20 to $23 in IPO
April 24, 2023
Tags
Health & Science
Breaking News: Business
Retail industry
From
CNBC.com News
CNN anchor Don Lemon is leaving the network
April 24, 2023
Tags
Breaking News: Business
Biotechnology
Media
From
CNBC.com News
U.S. bankruptcy judge halts 40,000 talc-cancer lawsuits against Johnson & Johnson
April 20, 2023
Tickers
LAW
LAWS
Tags
Breaking news
Health care industry
Laws
From
CNBC.com News
Nokia shares tank after it misses quarterly profit estimates
April 20, 2023
Tags
Companies
Earnings
Markets
From
CNBC.com News
Abbott Labs shares pop as revenue, earnings defy steep drop in Covid test sales
April 19, 2023
Tags
Earnings
Pharmaceuticals
Abbott Laboratories
From
CNBC.com News
Johnson & Johnson expects no new Covid vaccine revenue, after shots drive earnings beat
April 18, 2023
Tags
Biotechnology
Health & Science
Breaking News: Business
From
CNBC.com News
Johnson & Johnson beats on earnings and revenue, raises full-year guidance
April 18, 2023
Tags
Pharmaceuticals
Biotech and Pharmaceuticals
Earnings
From
CNBC.com News
Moderna shares fall despite promising data from cancer vaccine trial
April 17, 2023
Tags
Biotech and Pharmaceuticals
US: News
Companies
From
CNBC.com News
Twitter partners with eToro to let users trade stocks, crypto as Musk pushes app into finance
April 13, 2023
Tickers
CEO
CEOS
Tags
Social media
Markets
Volkswagen AG
From
CNBC.com News
Juul to pay $462 million to settle youth vaping claims from six states, D.C.
April 12, 2023
Tags
Companies
US: News
Biotech and Pharmaceuticals
From
CNBC.com News
Moderna says it expects up to $15 billion in sales of Covid, RSV, flu vaccines in 2027
April 11, 2023
Tags
Health care industry
Breaking news
Business News
From
CNBC.com News
Moderna says it hopes to offer new vaccines for cancer, heart disease, and other conditions by 2030
April 10, 2023
Tags
Breaking news
Health care industry
Pharmaceuticals
From
CNBC.com News
Pfizer CEO signs letter in support of FDA after federal judge suspends approval of abortion pill
April 10, 2023
Tickers
LAW
LAWS
Tags
Pfizer Inc
Politics
Social issues
From
CNBC.com News
Uber-owned Careem launches spinout with $400 million investment from UAE tech holding company e&
April 10, 2023
Tags
Companies
Uber Technologies Inc
Transportation
From
CNBC.com News
Alzheimer’s patients retain the benefits of Leqembi even when they stop the drug, Eisai says
April 06, 2023
Tags
Biotechnology
Eisai Co Ltd
Health care industry
From
CNBC.com News
Carl Icahn says Illumina’s appeal of FTC order to divest Grail is ‘an almost impossible battle’
April 05, 2023
Tags
Breaking news
Health care industry
Illumina Inc
From
CNBC.com News
Johnson & Johnson shares rise after company proposes baby powder cancer settlement
April 05, 2023
Tickers
LAW
LAWS
Tags
Biotechnology
U/S/ Markets
Breaking news
From
CNBC.com News
< Previous
1
2
...
20
21
22
23
24
25
26
27
28
...
30
31
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.